Islet Biology and Metabolism
This Special Issue of Metabolites, entitled "Islet Biology and Metabolism" is dedicated to islet research and the impact of islet function in metabolic health and disease. Specific topics include, but are not limited to, islet hormone processing and secretion, islet transplant research, no...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_78728 | ||
| 005 | 20220224 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220224s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-2736-9 | ||
| 020 | |a 9783036527369 | ||
| 020 | |a 9783036527376 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2736-9 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Kebede, Melkam |4 edt | |
| 700 | 1 | |a Yau, Belinda |4 edt | |
| 700 | 1 | |a Kebede, Melkam |4 oth | |
| 700 | 1 | |a Yau, Belinda |4 oth | |
| 245 | 1 | 0 | |a Islet Biology and Metabolism |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (192 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This Special Issue of Metabolites, entitled "Islet Biology and Metabolism" is dedicated to islet research and the impact of islet function in metabolic health and disease. Specific topics include, but are not limited to, islet hormone processing and secretion, islet transplant research, novel proteins of the insulin secretory pathway, as well as islet drug targets for the management of T1D and T2D. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a insulin secretory granule | ||
| 653 | |a beta-cells | ||
| 653 | |a granule protein purification | ||
| 653 | |a free fatty acid receptor (FFA) 2 | ||
| 653 | |a FFA3 | ||
| 653 | |a gut microbiome | ||
| 653 | |a incretin | ||
| 653 | |a insulin secretion | ||
| 653 | |a short-chain fatty acids | ||
| 653 | |a type 1 diabetes | ||
| 653 | |a cytosolic calcium concentration | ||
| 653 | |a glucose | ||
| 653 | |a metabolic amplification | ||
| 653 | |a mitochondria | ||
| 653 | |a nutrient secretagogues | ||
| 653 | |a diabetes | ||
| 653 | |a hypoglycemic unaware | ||
| 653 | |a ischaemia | ||
| 653 | |a islet cell transplantation | ||
| 653 | |a organ donation | ||
| 653 | |a pancreas | ||
| 653 | |a insulin | ||
| 653 | |a beta cell | ||
| 653 | |a human | ||
| 653 | |a islet | ||
| 653 | |a polarisation | ||
| 653 | |a machine learning | ||
| 653 | |a deep learning | ||
| 653 | |a cell segmentation | ||
| 653 | |a automation | ||
| 653 | |a pancreatic islets | ||
| 653 | |a leptin | ||
| 653 | |a exocytosis | ||
| 653 | |a tissue-engineering | ||
| 653 | |a in vivo imaging | ||
| 653 | |a metabolism | ||
| 653 | |a β-cell | ||
| 653 | |a viral transduction | ||
| 653 | |a transplantation | ||
| 653 | |a amplifying pathway | ||
| 653 | |a hyperglycemia | ||
| 653 | |a adenylyl cyclase | ||
| 653 | |a incretins | ||
| 653 | |a glucokinase | ||
| 653 | |a forskolin | ||
| 653 | |a cAMP | ||
| 653 | |a exenatide | ||
| 653 | |a islets | ||
| 653 | |a bioenergetics | ||
| 653 | |a glucose-stimulated insulin secretion | ||
| 653 | |a respiration | ||
| 653 | |a advanced glycation end products | ||
| 653 | |a alagebrium chloride | ||
| 653 | |a cross-link breaker | ||
| 653 | |a immunopeptidome | ||
| 653 | |a MIN6N8 cell line | ||
| 653 | |a NOD mouse | ||
| 653 | |a autoimmune diabetes | ||
| 653 | |a pancreatic beta-cells | ||
| 653 | |a intrauterine growth restriction | ||
| 653 | |a maternal obesity | ||
| 653 | |a developmental programming | ||
| 653 | |a islet amyloid polypeptide (IAPP) | ||
| 653 | |a granin | ||
| 653 | |a secretory pathway | ||
| 653 | |a trans-Golgi network (TGN) | ||
| 653 | |a granule | ||
| 653 | |a pancreatic β-cell | ||
| 653 | |a amino acid | ||
| 653 | |a aminoaciduria | ||
| 653 | |a diabetes incidence | ||
| 653 | |a insulitis | ||
| 653 | |a neutral amino acid transporter | ||
| 653 | |a non-obese diabetic mouse | ||
| 653 | |a pancreatic islet | ||
| 653 | |a Slc6a19 deficiency | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4819 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/78728 |7 0 |z DOAB: description of the publication |